Intracellular delivery of polymeric nanocarriers: a matter of size, shape, charge, elasticity and surface composition.
暂无分享,去创建一个
[1] Gaudenz Danuser,et al. Cargo- and adaptor-specific mechanisms regulate clathrin-mediated endocytosis , 2010, The Journal of cell biology.
[2] Robert B Sim,et al. Target pattern recognition by complement proteins of the classical and alternative pathways. , 2009, Advances in experimental medicine and biology.
[3] Y. Koyanagi,et al. Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy , 1996 .
[4] Cui Tang,et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.
[5] J. Engbersen,et al. Effect of chemical functionalities in poly(amido amine)s for non-viral gene transfection. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[6] S. Kannan,et al. The effect of surface functionality on cellular trafficking of dendrimers. , 2008, Biomaterials.
[7] Patrick Soon-Shiong,et al. Protein nanoparticles as drug carriers in clinical medicine. , 2008, Advanced drug delivery reviews.
[8] Juan B. Blanco-Canosa,et al. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. , 2011, ACS nano.
[9] S. Mitragotri,et al. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. , 2011, Advanced drug delivery reviews.
[10] Efstathios Karathanasis,et al. Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release. , 2012, ACS nano.
[11] Mark E. Davis. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. , 2009, Molecular pharmaceutics.
[12] P. Low,et al. Discovery and Development of Folic‐Acid‐Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases , 2008 .
[13] Arezou A Ghazani,et al. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.
[14] R. Hancock,et al. Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.
[15] Daniel Scherman,et al. pH-sensitive PEG lipids containing orthoester linkers: new potential tools for nonviral gene delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[16] Iseult Lynch,et al. Protein-nanoparticle interactions: What does the cell see? , 2009, Nature nanotechnology.
[17] I. Zuhorn,et al. Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[18] D. Thompson,et al. Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[19] R K Jain,et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.
[20] M. Ferrari,et al. A Theoretical Model for the Margination of Particles within Blood Vessels , 2005, Annals of Biomedical Engineering.
[21] D. Mukhopadhyay,et al. DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. , 2012, Nano letters.
[22] Vincent M Rotello,et al. Effect of nanoparticle surface charge at the plasma membrane and beyond. , 2010, Nano letters.
[23] Gaurav Sahay,et al. Endocytosis of nanomedicines. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[24] R. Jain,et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[25] Mauro Ferrari,et al. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[26] P. Janmey,et al. Tissue Cells Feel and Respond to the Stiffness of Their Substrate , 2005, Science.
[27] R. Wallis,et al. Paths reunited: Initiation of the classical and lectin pathways of complement activation. , 2010, Immunobiology.
[28] M. Belting. Heparan sulfate proteoglycan as a plasma membrane carrier. , 2003, Trends in biochemical sciences.
[29] M. Bryszewska,et al. Influence of PAMAM dendrimers on human red blood cells. , 2004, Bioelectrochemistry.
[30] Richard G. W. Anderson,et al. Caveolin targeting to late endosome/lysosomal membranes is induced by perturbations of lysosomal pH and cholesterol content , 2012, Molecular biology of the cell.
[31] Nicholas Melosh,et al. Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation. , 2012, Nano letters.
[32] T. Xia,et al. Toxic Potential of Materials at the Nanolevel , 2006, Science.
[33] Samir Mitragotri,et al. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[34] A. Prescott,et al. The coated pit and macropinocytic pathways serve distinct endosome populations , 1994, The Journal of cell biology.
[35] Christine Allen,et al. The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. , 2010, Molecular pharmaceutics.
[36] R. Jain,et al. Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.
[37] Vincent M. Rotello,et al. Tuning Payload Delivery in Tumour Cylindroids using Gold Nanoparticles , 2010, Nature nanotechnology.
[38] Li Shi,et al. Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[39] Satyajit Mayor,et al. Pathways of clathrin-independent endocytosis , 2007, Nature Reviews Molecular Cell Biology.
[40] Thommey P. Thomas,et al. Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy. , 2004, Bioconjugate chemistry.
[41] Liangfang Zhang,et al. Nanoparticle-induced surface reconstruction of phospholipid membranes , 2008, Proceedings of the National Academy of Sciences.
[42] H. Gresham,et al. Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice. , 2002, Blood.
[43] Efstathios Karathanasis,et al. The effects of particle size, density and shape on margination of nanoparticles in microcirculation , 2011, Nanotechnology.
[44] V. Fadok,et al. Apoptotic cell removal , 2001, Current Biology.
[45] Joseph M DeSimone,et al. Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[46] M. Ferrari. Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.
[47] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[48] H. McMahon,et al. Mechanisms of endocytosis. , 2009, Annual review of biochemistry.
[49] H. Shmeeda,et al. Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[50] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[51] U. Huth,et al. Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[52] G. Mcinerney,et al. A Differential Role for Macropinocytosis in Mediating Entry of the Two Forms of Vaccinia Virus into Dendritic Cells , 2010, PLoS pathogens.
[53] A. Ivanov,et al. Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? , 2008, Methods in molecular biology.
[54] D. Stolz,et al. Identification of endothelial cell–surface proteins as targets for diagnosis and treatment of disease , 1996, Nature Medicine.
[55] P. Choyke,et al. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.
[56] M. Conese,et al. Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[57] U. Holmskov,et al. Ficolins and FIBCD1: soluble and membrane bound pattern recognition molecules with acetyl group selectivity. , 2011, Molecular immunology.
[58] Dong Chen,et al. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. , 2010, Biomaterials.
[59] Huajian Gao,et al. Cellular uptake of elastic nanoparticles. , 2011, Physical review letters.
[60] M. Conese,et al. Gene Transfer by Means of Lipo- and Polyplexes: Role of Clathrin and Caveolae-Mediated Endocytosis , 2006, Journal of liposome research.
[61] Samir Mitragotri,et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[62] J. Kopeček,et al. Semitelechelic HPMA copolymers functionalized with triphenylphosphonium as drug carriers for membrane transduction and mitochondrial localization. , 2006, Biomacromolecules.
[63] Antony Thomas,et al. The shape of things to come: importance of design in nanotechnology for drug delivery. , 2012, Therapeutic delivery.
[64] T. Gauler,et al. New targeted treatments in lung cancer--overview of clinical trials. , 2004, Lung cancer.
[65] Patrick Couvreur,et al. Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis. , 2007, Biomacromolecules.
[66] Li Shi,et al. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers , 2010, Expert opinion on drug delivery.
[67] Shan Wang,et al. Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways. , 2011, Blood.
[68] Nikolai G. Khlebtsov,et al. Gold Nanoparticles in Biomedical Applications: Recent Advances and Perspectives , 2012 .
[69] E. Korn,et al. PHAGOCYTOSIS OF LATEX BEADS BY ACANTHAMOEBA , 1967, The Journal of cell biology.
[70] A. Ridley,et al. Phosphatidylserine (PS) induces PS receptor–mediated macropinocytosis and promotes clearance of apoptotic cells , 2001, The Journal of cell biology.
[71] Warren C W Chan,et al. Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.
[72] P. Roversi,et al. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates , 2009, Nature.
[73] Joseph M DeSimone,et al. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. , 2005, Journal of the American Chemical Society.
[74] Laetitia Gonzalez,et al. Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[75] Philip S Low,et al. Folate receptor-mediated drug targeting: from therapeutics to diagnostics. , 2005, Journal of pharmaceutical sciences.
[76] A. Maitra,et al. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. , 2000, International journal of pharmaceutics.
[77] H Akita,et al. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid , 2007, Gene Therapy.
[78] Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells , 2008 .
[79] J. Klein. Probing the interactions of proteins and nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[80] E. Shusta,et al. Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation , 2007, Pharmaceutical Research.
[81] Yong Ren,et al. Plasmid‐Templated Shape Control of Condensed DNA–Block Copolymer Nanoparticles , 2013, Advanced materials.
[82] Byron Ballou,et al. Noninvasive imaging of quantum dots in mice. , 2004, Bioconjugate chemistry.
[83] Silvia Muro,et al. Endothelial targeting of antibody-decorated polymeric filomicelles. , 2011, ACS nano.
[84] Mehrdad Hamidi,et al. Hydrogel nanoparticles in drug delivery. , 2008, Advanced drug delivery reviews.
[85] Simon Benita,et al. Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. , 2008, Biomacromolecules.
[86] J. Huwyler,et al. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat. , 1997, The Journal of pharmacology and experimental therapeutics.
[87] Jinming Gao,et al. Modeling particle shape-dependent dynamics in nanomedicine. , 2011, Journal of nanoscience and nanotechnology.
[88] Samir Mitragotri,et al. Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[89] P. Grutter,et al. Effect of mechanical properties of hydrogel nanoparticles on macrophage cell uptake , 2009 .
[90] D. Irvine,et al. Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.
[91] Clive G. Wilson,et al. Blood clearance and organ deposition of intravenously administered colloidal particles. The effects of particle size, nature and shape , 1982 .
[92] Christian Mühlfeld,et al. Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles. , 2010, Small.
[93] R. Müller,et al. Oligomers of the Arginine-rich Motif of the HIV-1 TAT Protein Are Capable of Transferring Plasmid DNA into Cells* 210 , 2003, The Journal of Biological Chemistry.
[94] Dai Fukumura,et al. Cationic Nanoparticles Have Superior Transvascular Flux into Solid Tumors: Insights from a Mathematical Model , 2012, Annals of Biomedical Engineering.
[95] V. Muzykantov,et al. Modulation of endothelial targeting by size of antibody-antioxidant enzyme conjugates. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[96] A. Harvey,et al. Multimodal analysis of PEI-mediated endocytosis of nanoparticles in neural cells. , 2011, ACS nano.
[97] D. Discher,et al. Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.
[98] T. Ishida,et al. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[99] Nancy A Monteiro-Riviere,et al. Mechanisms of quantum dot nanoparticle cellular uptake. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[100] Erkki Ruoslahti,et al. Targeting of drugs and nanoparticles to tumors , 2010, The Journal of cell biology.
[101] Li Shi,et al. Scalable imprinting of shape-specific polymeric nanocarriers using a release layer of switchable water solubility. , 2012, ACS nano.
[102] Chung-Yuan Mou,et al. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. , 2009, Small.
[103] Mauro Ferrari,et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.
[104] Samuel Zalipsky,et al. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. , 2004, Advanced drug delivery reviews.
[105] Sara Linse,et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.
[106] Shinsuke Sando,et al. A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. , 2004, Journal of the American Chemical Society.
[107] Joel G Pounds,et al. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[108] D. Irvine,et al. cell-membrane penetration by monolayer-protected nanoparticles , 2008 .
[109] Michel Vert,et al. Biodistribution of Long-Circulating PEG-Grafted Nanocapsules in Mice: Effects of PEG Chain Length and Density , 2001, Pharmaceutical Research.
[110] P. Couvreur,et al. Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.
[111] R. Andreesen,et al. Phagocytosis of Nanoparticles by Human Immunodeficiency Virus (HlV)-Infected Macrophages: A Possibility for Antiviral Drug Targeting , 1992, Pharmaceutical Research.
[112] Kenneth A. Dawson,et al. Protein–Nanoparticle Interactions , 2008, Nano-Enabled Medical Applications.
[113] Samir Mitragotri,et al. Polymer particles that switch shape in response to a stimulus , 2010, Proceedings of the National Academy of Sciences.
[114] Mary E Napier,et al. The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[115] R. Parton,et al. The multiple faces of caveolae , 2007, Nature Reviews Molecular Cell Biology.
[116] L. Brannon-Peppas,et al. Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.
[117] Walter Hu,et al. Shape-specific polymeric nanomedicine: emerging opportunities and challenges , 2011, Experimental biology and medicine.
[118] I. Zuhorn,et al. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.
[119] Samir Mitragotri,et al. Spontaneous shape reconfigurations in multicompartmental microcylinders , 2012, Proceedings of the National Academy of Sciences.
[120] Patrick Soon-Shiong,et al. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[121] Joseph M. DeSimone,et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.
[122] Victoria A. Higman,et al. His-384 Allotypic Variant of Factor H Associated with Age-related Macular Degeneration Has Different Heparin Binding Properties from the Non-disease-associated Form* , 2006, Journal of Biological Chemistry.
[123] A. Malik,et al. Protein transport across the lung epithelial barrier. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[124] Joseph M. DeSimone,et al. Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.
[125] Ning Gu,et al. Computational investigation of interaction between nanoparticles and membranes: hydrophobic/hydrophilic effect. , 2008, The journal of physical chemistry. B.
[126] Vladimir R Muzykantov,et al. Polymeric carriers: role of geometry in drug delivery. , 2008, Expert opinion on drug delivery.
[127] T. Daniels,et al. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. , 2006, Clinical immunology.
[128] Hongwei Liao,et al. Biomedical applications of plasmon resonant metal nanoparticles. , 2006, Nanomedicine.
[129] Ou Chen,et al. Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. , 2011, Angewandte Chemie.
[130] Jayanth Panyam,et al. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.
[131] Robert Langer,et al. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers , 2008, Proceedings of the National Academy of Sciences.
[132] Simon Benita,et al. Targeting of nanoparticles to the clathrin-mediated endocytic pathway. , 2007, Biochemical and biophysical research communications.
[133] S. Moghimi. Mechanisms of splenic clearance of blood cells and particles : towards development of new splenotropic agents , 1995 .
[134] Lin Zhu,et al. Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. , 2012, ACS nano.
[135] Gustavo Helguera,et al. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. , 2006, Clinical immunology.
[136] Samir Mitragotri,et al. Particle shape enhances specificity of antibody-displaying nanoparticles , 2013, Proceedings of the National Academy of Sciences.
[137] Matthew D. McDermott,et al. The hydrogel template method for fabrication of homogeneous nano/microparticles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[138] Warren C W Chan,et al. The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.
[139] S. Wise. Nanocarriers as an emerging platform for cancer therapy , 2007 .
[140] S Moein Moghimi,et al. Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering. , 2010, ACS nano.
[141] M. Michaelis,et al. Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain , 2006, Journal of Pharmacology and Experimental Therapeutics.
[142] V. Muzykantov,et al. Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1. , 2012, ACS nano.
[143] Sandra L. Schmid,et al. Regulated portals of entry into the cell , 2003, Nature.
[144] Gaurav Sahay,et al. The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents. , 2010, Biomaterials.
[145] T. Ishida,et al. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. , 2008, International journal of pharmaceutics.
[146] Kenneth A Dawson,et al. Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. , 2013, Journal of the American Chemical Society.
[147] Vladimir P Torchilin,et al. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. , 2002, Cancer research.
[148] Jonathan D. Ashley,et al. A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes. , 2013, ACS nano.
[149] Juergen Friedrich,et al. Spheroid-based drug screen: considerations and practical approach , 2009, Nature Protocols.
[150] Silvia Muro,et al. Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[151] M. Edidin,et al. Shrinking patches and slippery rafts: scales of domains in the plasma membrane. , 2001, Trends in cell biology.
[152] Stephanie E. A. Gratton,et al. The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.
[153] Jean-Paul Behr,et al. Intracellular delivery of nanometric DNA particles via the folate receptor. , 2002, Bioconjugate chemistry.
[154] A. Tsourkas,et al. Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. , 2008, Biomaterials.
[155] Tore-Geir Iversen,et al. Cellular trafficking of quantum dot-ligand bioconjugates and their induction of changes in normal routing of unconjugated ligands. , 2008, Nano letters.
[156] Taro Shimizu,et al. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[157] E. W. Meijer,et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[158] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[159] Samir Mitragotri,et al. Red blood cell-mimicking synthetic biomaterial particles , 2009, Proceedings of the National Academy of Sciences.
[160] Nicholas A Peppas,et al. Intelligent therapeutics: biomimetic systems and nanotechnology in drug delivery. , 2004, Advanced Drug Delivery Reviews.
[161] Kai Yang,et al. Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. , 2010, Nature nanotechnology.
[162] Samir Mitragotri,et al. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. , 2010, Current pharmaceutical design.